0001104659-16-145695.txt : 20160920
0001104659-16-145695.hdr.sgml : 20160920
20160920160332
ACCESSION NUMBER: 0001104659-16-145695
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160401
FILED AS OF DATE: 20160920
DATE AS OF CHANGE: 20160920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aegerion Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001338042
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202960116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 500-7867
MAIL ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aegerion Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harshbarger Benjamin
CENTRAL INDEX KEY: 0001653133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34921
FILM NUMBER: 161893965
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
a4.xml
4
X0306
4
2016-04-01
0
0001338042
Aegerion Pharmaceuticals, Inc.
AEGR
0001653133
Harshbarger Benjamin
C/O AEGERION PHARMACEUTICALS, INC.
ONE MAIN STREET, SUITE 800
CAMBRIDGE
MA
02142
0
1
0
0
General Counsel
Common Stock
2016-04-01
4
M
0
867
A
867
D
Common Stock
2016-04-01
4
F
0
273
3.55
D
594
D
Common Stock
2016-09-17
4
M
0
1642
A
2236
D
Common Stock
2016-09-17
4
F
0
532
1.78
D
1704
D
Restricted Stock Units
2016-04-01
4
M
0
867
0.00
D
Common Stock
867
1733
D
Restricted Stock Units
2016-09-17
4
M
0
1642
0.00
D
Common Stock
1642
3282
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
33.34% of the grant vested on April 1, 2016. Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer, an additional 33.33% of the units will vest on each of April 1, 2017 and April 1, 2018.
33.34% of the grant vested on September 17, 2016. Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer, an additional 33.33% of the units will vest on each of September 17, 2017 and September 17, 2018.
/s/ Jennifer Fitzpatrick, attorney-in-fact
2016-09-20